Illumina Inc. (ILMN) was rated outperform (buy) by a sell side firm here on Wednesday. I looked at shares of ILMN on Nov. 14 and wrote, "Traders could probe the long side of ILMN on a pullback or correction to the $220 area. Risk to $202." It looks like our recommendation could be stopped out with a loss very soon, so let's check out the charts and indicators of the provider of genetic analysis products again.
More from Stocks
We had the Fed's rate decision, jobs numbers, and mega-cap tech earnings land. But here's what was the wildest action.
These names have joined the ranks of the world's most elite dividend growth companies as Dividend Aristocrats and/or Dividend Kings.
Here's why the markets are sounding a lot like the campy 'Batman' show -- and how to make sure you don't succumb to the market's Joker.
One thing is clear: Apple's disappointments are far more correctable, and their cash flow is more diversified than either AMZN or GOOGL.